Skip to main content
Log in

Interrelation of Changes in the Left Ventricular Myocardium and Evidence of Clinical and Laboratory Indicators in Chronic Kidney Disease of Elderly

  • Published:
Advances in Gerontology Aims and scope Submit manuscript

Abstract

The incidence of cardiovascular and kidney disease with age is growing steadily worldwide. The factors for cardiovascular and kidney diseases are similar at elderly ages. Left ventricular hypertrophy (LVH) in chronic kidney disease (CKD) at an elderly age is not well understood. The goal of this study was to examine changes in a structural state of the left ventricular myocardium depending on the severity of clinical and laboratory manifestations of CKD in elderly patients. Clinical, laboratory, and instrumental examination of 62 patients at ages of 60 to 74 years (the young old) was carried out; the average age was 63.7 ± 3.66 years. The study involved the analysis of parameters of red blood, lipid spectrum, creatinine, daily proteinuria, C-reactive protein, and blood electrolytes. Glomerular filtration rate (GFR) was assessed using the CKD-EPI formula. The eccentric type was found to be the predominant variant of LVH at the early stages of CKD (S1, S2, and S3) at elderly ages. In the presence of renal failure (S4 and S5 of CKD), changes in the structure of the myocardium are characterized by a predominantly concentric type of left ventricular remodeling in the elderly. The factors associated with the development of left ventricular remodeling in elderly patients with CKD included age, arterial hypertension, anemia, dyslipidemia, and proteinuria, as well as an appreciable decline in the level of GFR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

REFERENCES

  1. Alekseev, I.A., Comparative analysis of the severity of left ventricular hypertrophy and contractile function of the myocardium in elderly and senile patients with arterial hypertension, Sib. Med. Obozr., 2017, no. 2, pp. 66–71. https://doi.org/10.20333/2500136-2017-2-66-71

  2. Anisimov, V.N., Aging and age-related diseases, Klin. Gerontol., 2005, vol. 11, no. 1, pp. 42–49.

    Google Scholar 

  3. Anisimov, V.N., Bordovskii, G.A., Finagentov, A.V., et al., Governmental support of older citizens: what kind of geriatrics does modern Russia need, Usp. Gerontol., 2020, vol. 33, no. 4, pp. 625–645. https://doi.org/10.34922/AE.2020.33.4.002

    Article  CAS  Google Scholar 

  4. Anisimov, V.N., Red’ko, A.A., Finagentov, A.V., et al., System support for improving the quality of life of older citizens in Russia: problems and prospects, Usp. Gerontol., 2020, vol. 33, no. 5, pp. 825–837. https://doi.org/10.34922/AE.2020.33.5.002

    Article  CAS  Google Scholar 

  5. Annan, K., UN Secretary-General, Opening Second World Assembly on Ageing in Madrid, Urges Plan of Action to build a Society for all ages, Madrid, 2002. http://www.un.org/ru/documents/decl_conv/declarations/ageing_program.shtml. Cited July 27, 2021.

  6. Barbarash, V.L., Kashtalap, V.V., and Krivoshapova, K.E., Elderly patient with ischemic heart disease, Med. Alfavit, 2021, no. 1, vol. 11, pp. 8–11. https://doi.org/10.33667/2078-5631-2021-11-8-11

    Article  Google Scholar 

  7. Lapteva, E.S., Ariev, A.L., Tsutsunava, M.R., and Arieva, G.T., Comprehensive geriatric assessment—resolved and unresolved issues (review), Adv. Gerontol., 2021, vol. 11, no. 4, pp. 333–340. https://doi.org/10.1134/S207905702104007X

    Article  Google Scholar 

  8. Levitskaya, E.S., Batyushin, M.M., Bondarenko, O.K., et al., Prediction of the development of fibrosis of the small arterial channel in patients with arterial hypertension and primary chronic glomerulonephritis, Kardiovaskulyarnaya, Ter. Profil., 2020, vol. 19, no. 3, p. 2491. https://doi.org/10.15829/1728-8800-2020-2491

    Article  Google Scholar 

  9. Murkamilov, I.T., Sabirov, I.S., Aitbaev, K.A., et al., Renal dysfunction and indicators of arterial stiffness in elderly and senile patients, Usp. Gerontol., 2018, vol. 31, no. 4, pp. 549–555.

    CAS  Google Scholar 

  10. Murkamilov, I.T., Aitbaev, K.A., Fomin, V.V., et al., Clinical and functional features of arterial stiffness in the elderly people, Sist. Gipertenzii, 2021, vol. 18, no. 1, pp. 31–36. https://doi.org/10.26442/2075082X.2021.1.200721

    Article  Google Scholar 

  11. Ostroumova, O.D., Alyautdinova, I.A., Butorov, V.N., et al., Optimization of pharmacotherapy in a polymorbid patient with a combination of chronic heart failure and chronic kidney disease: a clinical case, Consilium Med., 2020, vol. 22, no. 1, pp. 38–43.

    Article  Google Scholar 

  12. Paketov, S.A., Oskolkov, S.A., Zhmurov, V.A., et al., Central hemodynamic parameters according to echocardiography in patients with chronic kidney disease on the background of chronic pyelonephritis, Med. Nauka Obarz. Urala, 2020, vol. 21, no. 3, pp. 73–75. https://doi.org/10.36361/1814-8999-2020-21-3-73-75

    Article  Google Scholar 

  13. Rubinskii, A.V., Lin’kova, N.S., Chalisova, N.I., et al., Epigenetic regulation of adaptogenesis in pathology and aging, Usp. Gerontol., 2021, vol. 34, no. 1, pp. 10–17. https://doi.org/10.34922/AE.2021.34.1.001

    Article  CAS  Google Scholar 

  14. Smirnov, A.V., Dobronravov, V.A., Kayukov, I.G., et al., Epidemiology and socioeconomic aspects of chronic kidney disease, Nefrologiya, 2006, vol. 10, no. 1, pp. 7–13. https://doi.org/10.24884/1561-6274-2006-10-1-7-13

    Article  Google Scholar 

  15. Storozhakov, G.I., Chervyakova, Yu.B., Vereshchagin, G.S., et al., Elastic properties of the arterial wall in elderly patients with arterial hypertension, Klin. Gerontol., 2006, vol. 10, pp. 33–38.

    Google Scholar 

  16. Khurs, E.M., Poddubnaya, A.V., and Evsina, M.G., Influence of dyslipidemia on early structural-geometric reorganization of the heart in patients with arterial hypertension, Arterial’naya Gipertenziya, 2010, vol. 16, no. 5, pp. 511–516. https://doi.org/10.18705/1607-419X-2010-5-

    Article  Google Scholar 

  17. Chazova, I.E. and Zhernakova, Yu.V., Expert opinion. Clinical guidelines: diagnostics and treatment of arterial hypertension, Sist. Gipertenzii, 2019, vol. 16, no. 1, pp. 6–31. https://doi.org/10.26442/2075082X.2019.1.190179

    Article  Google Scholar 

  18. Chernyavina, A.I. and Koziolova, N.A., The relationship of left ventricular hypertrophy with impaired filtration and tubulointerstitial functions of the kidneys in patients with hypertension, Neotlozhnaya Kardiol. Kardiovaskulyarnye Riski, 2020, vol. 4, no. 1, pp. 861–866. http://rep.bsmu.by:8080/handle/BSMU/29006

  19. Atkins, R.C., The epidemiology of chronic kidney disease, Kidney Int. Suppl., 2005, vol. 94, pp. S14–S18. https://doi.org/10.1111/j.1523-1755.2005.09403.x

    Article  Google Scholar 

  20. Gluba-Brzózka, A., Franczyk, B., Olszewski, R., et al., The influence of inflammation on anemia in CKD patients, Int. J. Mol. Sci., 2020, vol. 21, no. 3, p. 725. https://doi.org/10.3390/ijms21030725

    Article  CAS  PubMed Central  Google Scholar 

  21. Harper, C.R. and Jacobson, T.A., Managing dyslipidemia in chronic kidney disease, J. Am. College Cardiol., 2008, vol. 51, no. 25, pp. 2375–2384.

    Article  CAS  Google Scholar 

  22. Iseki, K., Iseki, C., Ikemiya, Y., and Fukiyama, K., Risk of developing end-stage renal disease in a cohort of mass screening, Kidney Int., 1996, vol. 49, no. 3, pp. 800–805. https://doi.org/10.1038/ki.1996.111

    Article  CAS  PubMed  Google Scholar 

  23. Kalu, O.K., Hart, O.C., Ifeoma, C.N., et al., Patterns and predictors of left ventricular hypertrophy in Nigerians with chronic kidney disease, Ann. Clin. Cardiol., 2021, vol. 3, no. 1, pp. 33–38. https://doi.org/10.4103/ACCJ.ACCJ_41_20

    Article  Google Scholar 

  24. Kim, I.Y., Ye, B.M., Kim, M. J., et al., Association between serum uric acid and left ventricular hypertrophy/left ventricular diastolic dysfunction in patients with chronic kidney disease, PLoS One, 2021, vol. 16, no. 5, p. e0251333. https://doi.org/10.1371/journal.pone.0251333

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lang, R.M., Badano, L.P., Mor-Avi, V., et al., Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Eur. Heart J. Cardiovasc. Imaging, 2015, vol. 16, no. 3, pp. 233–271.

    Article  Google Scholar 

  26. Levey, A.S., Coresh, J., Bolton, K., et al., K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am. J. Kidney Dis., 2002, vol. 39, suppl. 1, p. 2.

    Google Scholar 

  27. Lurbe, E., Agabiti-Rosei, E., Cruickshank, J.K., et al., 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents, J. Hypertens., 2016, vol. 34, no. 10, pp. 1887–1920.

    Article  CAS  Google Scholar 

  28. Majoni, S.W., Lawton, P.D., Rathnayake, G., et al., Narrative review of hyperferritinemia, iron deficiency, and the challenges of managing anemia in aboriginal and Torres Strait islander Australians with CKD, Kidney Int. Rep., 2021, vol. 6, no. 2, pp. 501–512. https://doi.org/10.1016/j.ekir.2020.10.035

    Article  PubMed  Google Scholar 

  29. McCullough, P.A., Anemia of cardiorenal syndrome, Kidney Int. Suppl., 2021, vol. 11, no. 1, pp. 35–45. https://doi.org/10.1016/j.kisu.2020.12.001

    Article  Google Scholar 

  30. Podestà, M.A., Valli, F., Galassi, A., et al., The impact of old and novel cardiovascular risk factors, Blood Purif., 2021, vol. 50, pp. 740–749. https://doi.org/10.1159/000514467

    Article  CAS  PubMed  Google Scholar 

  31. Zicarelli, M.T., Patella, G., Bolignano, D., et al., Nephrosclerosis impacts time trajectory of renal function and outcomes in elderly individuals with chronic kidney disease, J. Invest. Med., 2021, vol. 69, pp. 1411–1416. https://doi.org/10.1136/jim-2021-001854

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. T. Murkamilov.

Ethics declarations

Conflict of interests. The authors declare that they have no conflict of interest.

Statement of compliance with standards of research involving humans as subjects. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study. Informed consent was obtained from all individual participants involved in the study.

Additional information

Translated by E. Kuznetsova

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murkamilov, I.T., Sabirov, I.S., Fomin, V.V. et al. Interrelation of Changes in the Left Ventricular Myocardium and Evidence of Clinical and Laboratory Indicators in Chronic Kidney Disease of Elderly. Adv Gerontol 12, 72–78 (2022). https://doi.org/10.1134/S207905702201009X

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S207905702201009X

Keywords:

Navigation